Supporting GLP-1 naturally is not about replacing medical care or mimicking drug effects
Table 3 Key ICIs based clinical trials against TNBC
Its modified structure allows for increased stability, meaning it remains active longer than native GHRH peptides
23 (1), e0202
In a phase 2 trial published in The New England Journal of Medicine, Retatrutide was associated with substantial body weight reductions over 48 weeks in adults with obesity, with the 12 mg group showing a mean percentage change of -24.2% compared with -2.1% for placebo
Featuring StabiliPro Inulin for prebiotic fiber, fortified with Calcium Bisglycinate Chelate and Vitamin D, this convenient and flavorful, this concept is designed to support satiety, digestive health, and bone health, all in one easy-to-mix solution.